2015 Year in review

from Healthcare Economist at http://bit.ly/1ZDehQW on December 31, 2015 at 08:46AM My review of 2015 year in review posts from a variety of sources.  Enjoy. CBS News medical stories of 2015.  N.Y. Times take on 2015’s the top health and medical stories. Best Marginal Revolution posts. Managed Care Matters update on the ACA: Part I […]

happy new 2016

from Terry Flynn PhD at http://bit.ly/1RRhTNV on December 30, 2015 at 12:15PM A slightly early happy new year post! It has certainly been a bit of a roller-coaster year for me – finishing in Australia, spending 5 months in Sweden, before returning to my home town to set up my own company. Things are settling […]

Are “Focused Factories” a good idea?

from Healthcare Economist at http://bit.ly/1Vp68gE on December 30, 2015 at 06:25AM In recent years, there has a been a trend towards patient-centered care focusing on caring for a patient holistically.  For instance, a NEJM perspective piece by Porter states: Accountability for value should be shared among the providers involved. Thus, rather than “focused factories” concentrating on […]

Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?

from Latest Results for PharmacoEconomics at http://bit.ly/1RQ8CWs on December 29, 2015 Abstract Health systems worldwide are facing difficult choices about the use of a series of highly effective but costly new treatments for hepatitis C. In this paper we discuss how the National Institute for Health and Care Excellence in England and Wales, the Common […]

Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension

from Latest Results for PharmacoEconomics at http://bit.ly/1PvS6HC on December 29, 2015 Abstract Background Pulmonary arterial hypertension (PAH), as a life-threatening disease with no efficient cure, may impose a tremendous economic burden on patients and healthcare systems. However, most existing studies have mainly emphasised epidemiology and medications, while large observational studies reporting on the economic burden […]

Complex Valuation: Applying Ideas from the Complex Intervention Framework to Valuation of a New Measure for End-of-Life Care

from Latest Results for PharmacoEconomics at http://bit.ly/1RQ8AOg on December 29, 2015 Abstract Background The UK Medical Research Council approach to evaluating complex interventions moves through development, feasibility, piloting, evaluation and implementation in an iterative manner. This approach might be useful as a conceptual process underlying complex valuation tasks. Objective The objective of the study was […]

Cost Prediction Using a Survival Grouping Algorithm: An Application to Incident Prostate Cancer Cases

from Latest Results for PharmacoEconomics at http://bit.ly/1PvS56I on December 29, 2015 Abstract Background Prognostic classification approaches are commonly used in clinical practice to predict health outcomes. However, there has been limited focus on use of the general approach for predicting costs. We applied a grouping algorithm designed for large-scale data sets and multiple prognostic factors […]

Quality of life in Iranian patients with bipolar disorder: a psychometric study of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD)

from Latest Results for Quality of Life Research at http://bit.ly/1MFcWjr on December 29, 2015 Abstract Purpose To assess the reliability, validity, and factor structure of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD) in Iranian patients with bipolar disorder (BD). Methods After translation and cross-cultural adaptation of the Brief QoL.BD, we administered the […]

The Year of the Hacker

from THCB at http://bit.ly/1NOwwhg on December 29, 2015 at 05:24PM By JK Wall 2015 was the year health care got serious about cyber security. Hackers gave the industry no other choice. The year started with a massive data breach at Indianapolis-based Anthem Inc., which the health insurer revealed on Feb. 4. Hackers roamed around in […]

Dead is dead. Right?

from The Incidental Economist at http://bit.ly/1kq39aj on December 29, 2015 at 03:11PM From JAMA Neurology, “Variability of Brain Death Policies in the United States“: Importance  Brain death is the irreversible cessation of function of the entire brain, and it is a medically and legally accepted mechanism of death in the United States and worldwide. Significant […]